NCT02176551View on ClinicalTrials.gov

Study Comparing Product 0405 to a Vehicle Control in the Treatment of Mild to Moderate Atopic Dermatitis in Pediatric Subjects

PHASE3WithdrawnINTERVENTIONAL
0
Timeline

Start Date

June 30, 2012

Primary Completion Date

May 31, 2013

Study Completion Date

May 31, 2013

Conditions
Atopic Dermatitis
Interventions
DRUG

Product 0405

Product 0405 will be administered topically twice daily for 28 days.

DRUG

Placebo for Product 0405

Placebo for Product 0405 will be administered topically twice daily for 28 days.

Sponsors
All Listed Sponsors
lead

Fougera Pharmaceuticals Inc.

INDUSTRY